David Ridley_FDA foreign inspections_Duke University's Fuqua School of Business
Dec 13, 2023

Duke professors found that foreign inspections never returned to pre-pandemic levels, leading to drug safety concerns

During the pandemic, the U.S. Food and Drug Administration stopped most of their foreign inspections of drug manufacturers. “It was understandable,” said Professor David Ridley of Duke University’s Fuqua School of Business, as lockdowns and travel restrictions brought disruptions both globally and at home. But in a paper published... read more